Try our Advanced Search for more refined results
Connecticut et al v. Aurobindo Pharma USA, Inc. et al
Case Number:
3:16-cv-02056
Court:
Nature of Suit:
Judge:
Firms
- Arnold & Porter
- Baker Botts
- Buchanan Ingersoll
- Clifford Chance
- Day Pitney
- Dechert LLP
- Duane Morris
- Foley & Lardner
- Gibson Dunn
- Greenberg Traurig
- Hogan Lovells
- Kasowitz Benson
- K&L Gates
- Morgan Lewis
- Morrison Foerster
- Murtha Cullina
- O'Toole & O'Toole
- Patterson Belknap
- Proskauer Rose
- Pullman & Comley
- Reed Smith
- Shipman & Goodwin
- Wiggin & Dana
- Williams & Connolly
- WilmerHale
- Wilson Sonsini
Companies
- Allergan PLC
- Ascend Laboratories LLC
- Aurobindo Pharma Ltd.
- Avet Pharmaceuticals Inc.
- Dr. Reddy's Laboratories Ltd.
- Emcure Pharmaceuticals Ltd.
- Glenmark Pharmaceuticals Ltd.
- Lannett Company, Inc
- Sandoz International GmbH
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
- Zydus Pharmaceuticals Inc.
Government Agencies
- Commonwealth of Kentucky
- Commonwealth of Massachusetts
- State of Indiana
- State of Maryland
- State of Michigan
- State of Nevada
- State of Tennessee
- U.S. District Court for the District of Columbia
Sectors & Industries:
-
April 25, 2024
Conn. Judge In Drug Price-Fixing Suit Reveals Day Pitney Ties
U.S. District Judge Michael P. Shea of the District of Connecticut said Thursday he will not recuse himself from overseeing state enforcers' price-fixing claims against Sandoz Inc. and other drug companies despite Sandoz's attorneys being from Day Pitney LLP, where he was once a partner.
-
February 01, 2024
State-Led Generic Drug Cases Removed From MDL
The Judicial Panel on Multidistrict Litigation has sent a trio of cases from state-level enforcers back to federal court in Connecticut, separating them from the sprawling MDL centralized in Pennsylvania over claims of price fixing in the generic drug industry.
-
May 23, 2017
40 States Defend Power To Bring Generic-Drug Price-Fix Suit
Forty states on Monday defended their lawsuit against six generic-drug manufacturers alleging they divided the market and fixed the price of an antibiotic and a diabetes treatment, saying they have the authority to seek an injunction and monetary relief under federal antitrust law.
-
May 03, 2017
Generic-Drug Makers Want 40-State Price-Fix Suit Dropped
Six generic-drug makers accused of conspiring to fix the prices of an antibiotic and a diabetes medication have asked a Connecticut federal court to toss the suit now joined by 40 states, saying the complaint contains a multitude of legal flaws.
-
March 01, 2017
20 More States Join Generic Drug-Pricing Antitrust Action
Forty states are now bringing antitrust claims against six generic-drug makers including Heritage, Mylan and Teva, alleging they conspired to fix the prices of an antibiotic and a diabetes medication, according to an amended complaint filed in Connecticut federal court Wednesday.
-
February 09, 2017
Feds Look To Intervene In 20-State Drug Antitrust Suit
The U.S. government on Thursday asked a Connecticut federal court for permission to intervene in an antitrust action from 20 states against six generic-drug makers including Heritage, Mylan and Teva, citing the need to "protect the integrity" of its own investigation into the generic pharmaceutical industry.
-
December 15, 2016
20 States Sue Generic-Drug Companies Over Collusion
Twenty states announced Thursday they have filed a lawsuit against generic-drug makers including Heritage, Teva, Mylan and three others alleging the companies conspired to fix prices and constrain competition for antibiotics and diabetes treatments.
- ← Previous
- 1
- 2
- Next →